4Madrid AH, Bueno MG, Rebollo JM, et al. Use of irbesartan to maintain sinus rhyhmin patients with long - lasting persistent atrial fbrillation[J]. Circulation, 2002, 106: 331.
5Healey JS, Barancuk A, Crystal E, et al. Revertion of atrial fibrillation with angiotension - converting enzyme inhibitors and angiotension receptor blocks [ J ]. J Am Coil Cardiol, 2005, 45 : 1832.
6Thomas D, Kathofer S, Zhang W, et al. Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channels. Br J Pharmacol,2003,140:996-1002.
7Shingawa K, Shiroshita-Takeshita A, Schram G, et al. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium:insights into the mechanism of the superior efficacy of amiodarone. Circulation,2003,107:1440-1446.
8Haikerwal D, Esler MD, Dart AM. Acute electrophysiologic effects of intravenous amiodarone are independent of a sympatholytic action in humans. J Cardiovasc Pharmacol, 2003,41:760-765.
9Letelier LM, Udol K, Ena J, et al. Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a metaanalysis. Arch Intern Med,2003 ,163 :777-785.
10Khan IA, Mehta NJ, Gowda RM. Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation. Int J Cardiol, 2003,89: 239-248.
